Histogenics (HSGX) Misses Q3 EPS by 21c

November 10, 2016 6:56 AM EST
Get Alerts HSGX Hot Sheet
Trade HSGX Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Histogenics (NASDAQ: HSGX) reported Q3 EPS of ($0.70), $0.21 worse than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Histogenics (HSGX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment